Radioiodine (131I) therapy of benign thyroid diseases was introduced 70 yr ago, and the
patients treated since then are probably numbered in the millions. Fifty to 90% of …

Damage from occupational or accidental exposure to ionising radiation is often assessed by
monitoring chromosome aberrations in peripheral blood lymphocytes, and these procedures …

Background: Radioactive iodine (RAI) is widely used for the treatment of thyroid cancers.
However, information on associations between RAI dose and second primary malignancy …

It is hypothesized that the oxidative stress level in thyroid cancer patients is additionally
upregulated by radioactive iodine (RAI) treatment, that may exert an important impact on …

The aim of this study was to evaluate and compare the oxidative profiles of three thyroid
disorders: Graves' disease (GD), Hashimoto thyroiditis (HT), and papillary thyroid cancer …

Thyroid cancer is the most common endocrine cancer, and its prevalence has been
increasing for decades. Approx. 95% of differentiated thyroid carcinomas are treated using …

Exposure to ionizing radiation increases the risk of myelodysplastic syndromes (MDS) and
myeloproliferative neoplasms (MPN), but such risks are not known in well-differentiated …

Radioiodine 131 (131I) has been used worldwide for the ablation of remnant thyroidal tissue
after surgery or as the first-line treatment for Graves' disease. Although the use of 131I is …

Background: 131-radioiodine has been widely used as an effective radionuclide for
treatment of patients with thyroid diseases. The purpose of the present study is to investigate …

The study of ionising radiation has systematically relied on cytogenetic indicators to evaluate
the biological effects and has led to theoretical approaches to explain observations …